Intranasal insulin is linked to improvements in cognition and gait in elderly patients with type 2 diabetes, researchers say.
Plant-based diet may lower type 2 diabetes risk … Intranasal insulin may slow dementia … Multi-year trial shows PPIs largely safe … Breaking neuropathy news: FDA approves first Lyrica generics
Older adults with diabetes who took insulin through their nose showed cognitive improvement, a small pilot study finds.
Please login or register first to view this content.
Login Register